Israel Biotech Fund Ii, L.P.
Venture Capital Fund · Cayman Islands
Advised by I.B.F. Management Ltd. · reported Feb 2024
Gross asset value
$25.0M
Beneficial owners
61
Minimum investment
$25.0K
Adviser & related persons own
5%
Structure & investors
- SEC fund ID
- 805-8407432731
- Exclusion
- 3(c)(1)
- Fund of funds
- No
- Owned by funds of funds
- 0%
- Non-US ownership
- 40%
- Adviser's clients invested
- 0%
Reported by the adviser in Form ADV Section 7.B.(1), filing of February 2024. Figures are as reported by the adviser and not independently verified.